ABOVE: © ISTOCK.COM, WHYFRAMESTUDIO
Update (June 3): The World Health Organization today announced that it would be resuming hydroxychloroquine testing in its Solidarity Trial, following widespread criticism of The Lancet paper and the dataset it was based on.
Scientists are questioning the validity of two influential studies of COVID-19 patients as concerns grow about the provenance of the dataset underpinning them. Despite assurances from Surgisphere Corporation, an Illinois-based company that owns the data, hundreds of researchers have now signed open letters to The Lancet and the New England Journal of Medicine (NEJM), voicing their concerns. Today, NEJM and The Lancet issued expressions of concern about the reliability of the papers’ conclusions.
“Recently, substantive concerns have been raised about the quality of the information in that database,” writes NEJM editor-in-chief Eric Rubin in the expression of concern. “We have asked the authors to provide evidence that the data are reliable. In ...
